Home LiteratureArticle Details
PMID: 15574760 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes.

Cancer research ·Vol. 64 ·No. 23 ·2004-12-01 ·Pages 8541-9

Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, Schubert EL, Holcomb IN, Massa HF, Glogovac J, Li CI, Malone KE, Daling JR, Delrow JJ, Trask BJ, Hsu L, Porter PL

Abstract

In this study, we performed high-resolution array comparative genomic hybridization with an array of 4153 bacterial artificial chromosome clones to assess copy number changes in 44 archival breast cancers. The tumors were flow sorted to exclude non-tumor DNA and increase our ability to detect gene copy number changes. In these tumors, losses were more frequent than gains, and gains in 1q and loss in 16q were the most frequent alterations. We compared gene copy number changes in the tumors based on histologic subtype and estrogen receptor (ER) status, i.e., ER-negative infiltrating ductal carcinoma, ER-positive infiltrating ductal carcinoma, and ER-positive infiltrating lobular carcinoma. We observed a consistent association between loss in regions of 5q and ER-negative infiltrating ductal carcinoma, as well as more frequent loss in 4p16, 8p23, 8p21, 10q25, and 17p11.2 in ER-negative infiltrating ductal carcinoma compared with ER-positive infiltrating ductal carcinoma (adjusted P values < or = 0.05). We also observed high-level amplifications in ER-negative infiltrating ductal carcinoma in regions of 8q24 and 17q12 encompassing the c-myc and c-erbB-2 genes and apparent homozygous deletions in 3p21, 5q33, 8p23, 8p21, 9q34, 16q24, and 19q13. ER-positive infiltrating ductal carcinoma showed a higher frequency of gain in 16p13 and loss in 16q21 than ER-negative infiltrating ductal carcinoma. Correlation analysis highlighted regions of change commonly seen together in ER-negative infiltrating ductal carcinoma. ER-positive infiltrating lobular carcinoma differed from ER-positive infiltrating ductal carcinoma in the frequency of gain in 1q and loss in 11q and showed high-level amplifications in 1q32, 8p23, 11q13, and 11q14. These results indicate that array comparative genomic hybridization can identify significant differences in the genomic alterations between subtypes of breast cancer.

MeSH Terms
Adult Aged Breast Neoplasms/genetics,metabolism,pathology Carcinoma, Ductal, Breast/genetics,metabolism,pathology Carcinoma, Lobular/genetics,metabolism,pathology DNA, Neoplasm/analysis,genetics Female Flow Cytometry Gene Dosage Humans Middle Aged Nucleic Acid Hybridization Receptors, Estrogen/biosynthesis Reproducibility of Results
Chemicals
DNA, Neoplasm Receptors, Estrogen
Authors & Affiliations
16 authors, click to expand affiliations / ORCID
Loo Lenora W M
Division of Human Biology, Division of Public Health Sciences, and Genomics Shared Resource, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Grove Douglas I
Williams Eleanor M
Neal Cassandra L
Cousens Laura A
Schubert Elizabeth L
Holcomb Ilona N
Massa Hillary F
Glogovac Jeri
Li Christopher I
Malone Kathleen E
Daling Janet R
Delrow Jeffrey J
Trask Barbara J
Hsu Li
Porter Peggy L
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
2004-12-01
Pages
8541-9
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Grants
NICHD NIH HHS · N01-HD2-3166 · United States
PHS HHS · P30 15704-30 · United States
NCI NIH HHS · P50 CA97186 · United States
NIA NIH HHS · R01 AG14358 · United States
NCI NIH HHS · R01 CA95717 · United States
NCI NIH HHS · U24 CA80295 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]